Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients

NCT ID: NCT07141940

Last Updated: 2025-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-06

Study Completion Date

2025-08-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if guided imagery therapy using mobile application in Indonesian language can improve sleep quality and lower fasting blood glucose levels in diabetics patients who have problems with their sleep.

The main questions it aims to answer are:

* Can the app-based guided imagery therapy help improve sleep quality in diabetic patients who have trouble sleeping?
* Can the app-based guided imagery therapy help lowering fasting blood glucose in diabetic patients who have trouble sleeping? Researchers will compare app-based guided imagery therapy to education about how to sleep well, to see if the app works to improve sleep quality and lower blood glucose.

Participants will:

* Receive education about how to sleep well
* Use the app 3 times a week for 4 weeks (only for group who receive the app)
* Visit the clinic after 4 weeks for tests

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes (Insulin-requiring, Type 1 or Type 2) Insomnia Type; Sleep Disorder Fasting Plasma Glucose

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

The participants receive psychoeducation at the enrollment. Then, they were asked to use the Indonesian-language application-based auditory guided imagery therapy 3 times a week for 4 weeks.

Group Type EXPERIMENTAL

Indonesian-language application-based auditory guided imagery therapy

Intervention Type OTHER

This study used a mobile application developed by researchers using Indonesian language to deliver an auditory guided imagery therapy

Control Group

The participants receive only psychoeducation at the enrollment.

Group Type ACTIVE_COMPARATOR

Psychoeducation

Intervention Type OTHER

Psychoeducation consists of sleep hygiene and relaxation therapy (breathing exercise, progressive muscle relaxation, and guided imagery)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indonesian-language application-based auditory guided imagery therapy

This study used a mobile application developed by researchers using Indonesian language to deliver an auditory guided imagery therapy

Intervention Type OTHER

Psychoeducation

Psychoeducation consists of sleep hygiene and relaxation therapy (breathing exercise, progressive muscle relaxation, and guided imagery)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients at Endocrinology or Psychosomatic Clinic, Cipto Mangunkusumo Hospital
* Already diagnosed with Diabetes Mellitus
* HbA1c less than 12%
* Insomnia Severity Index more than 8
* Lives in Jakarta, Bogor, Depok, Tangerang, or Bekasi
* Able to understand the Indonesian language well

Exclusion Criteria

* History of amputation or routine hemodialysis
* No device available to connect with the application
* Inability to independently access or use the application
* Inability to perform self-monitoring of blood glucose at home
* Hearing impairment
* Cognitive impairment or intellectual limitations
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr Cipto Mangunkusumo General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rudi Putranto

Dr. dr. Rudi Putranto, Sp.PD, K-P.P.M, MPH

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rudi Putranto, Internist, MPH, PhD

Role: PRINCIPAL_INVESTIGATOR

Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cipto Mangunkusumo Hospital

Jakarta Pusat, Jakarta Special Capital Region, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RSCM_IPD_PPM_2025.01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.